|本期目录/Table of Contents|

[1]张建美,许皖,钟赣生,等.大戟甘草反药组合宜忌条件的实验研究回顾与评析[J].环球中医药,2015,8(09):1059-1063.[doi:10.3969/jissn.1674-1749.2015.09.007]
 ZHANG Jian mei,XU Wan,ZHONG Gan sheng,et al.Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility euphorbia pekinensis and glycyrrhiza[J].,2015,8(09):1059-1063.[doi:10.3969/jissn.1674-1749.2015.09.007]
点击复制

大戟甘草反药组合宜忌条件的实验研究回顾与评析()
     
分享到:

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第8卷
期数:
2015年09期
页码:
1059-1063
栏目:
反药组合研究专题
出版日期:
2015-09-06

文章信息/Info

Title:
Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility euphorbia pekinensis and glycyrrhiza
作者:
张建美许皖钟赣生郭岩松柳海艳欧丽娜赵桐刘佳王思睿
100029北京中医药大学基础医学院
Author(s):
ZHANG Jianmei XU Wan ZHONG Gansheng et al.
School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing 100029, China
关键词:
十八反大戟甘草反药组合宜忌条件
Keywords:
Eighteen antagonismsEuphorbia pekinensisGlycyrrhizaAntagonism compatibilitySuitable and contraindicant conditions
分类号:
R285.5
DOI:
10.3969/jissn.1674-1749.2015.09.007
文献标志码:
A
摘要:
利用中国知网、万方、维普、PubMed数据库,系统检索1949年以来关于“十八反”中大戟甘草反药组合同用的研究文献,检索文章的过程中剔除综述及临床研究类文章,选取实验研究方面的文章,总结归纳大戟甘草反药组合配伍使用的宜忌条件。结果显示对大戟与甘草配伍宜忌条件的研究多集中在配伍剂量、配伍比例、煎煮方式、给药途径、大戟品种等方面。在给药剂量方面,按照临床规定安全剂量给药时大部分表现为“不反”;而两药的倍量使用,则表现出一定的相反趋势。给药途径方面,腹腔注射是禁忌条件。而其他几方面未区分出明确的“反”与“不反”的条件。笔者认为大戟甘草能否同用不能一概而论,而是受到不同条件的限制,单一条件下得出的结果只能作为参考,而不能成为定论。且发现实验研究多在生理条件下对单纯反药组合进行探讨,希望今后病理状态下含反药组合的复方研究能引起人们的重视,使“十八反”的研究更具临床指导意义。
Abstract:
This article summarized the suitable conditions and contraindicant conditions of antagonism compatibility euphorbia pekinensis and glycyrrhiza from the selected experimental research articles by searching “euphorbia pekinensis and glycyrrhiza compatibility of Chinese medicine Eighteen antagonism” from Wan Fang, CNKI, and VIP database since 1949. The studies of suitable and contraindicant conditions of euphorbia pekinensis and glycyrrhiza focused on proportion, dose, method of decoction,route of administration, varieties of euphorbia pekinensis, and so on. The result is that the dose around to the clinical dose is the suitable conditions, while the contraindicant condition is as twice as the clinical dose. On the route of administration, injecting is contraindicant condition. While other conditions can’t be classified clearly into suitable and contraindicant ones. In my opinion, whether euphorbia pekinensis and glycyrrhiza can be used together or not is limited by different conditions but can’t be generalized in a few words. The results obtained under a single condition can only be as a reference, but not be conclusive. What’s more, we find that, the experiment researches are usually took under physiological conditions and the object is purely antagonism compatibility itself. We hope more researches will be done under pathological conditions so that providing important evidences for the clinician.

参考文献/References:

[1]许瑞,陶伟伟,段金廒,等.基于对小鼠利尿与泻下作用探讨京大戟与甘草配伍禁忌的理论依据[J].中草药,2014,45(14):20562059.
[2]王丹,康健.中药剂量与药效的相关性研究[J].河南中医,2013,33(7):11581159.
[3]张永浩,陈必忠.中药十八反中甘草、大戟、甘遂对小白鼠作用的初步试验观察[J].西安交通大学学报(医学版),1959,(1):913.
[4]杨致礼,王佑之,吴成林,等.中药十八反在家兔上的毒性试验——中药十八反研究报告之二[J].甘肃农大学报,1986,(4):922.
[5]郑动才,黄朝义,张余森,等.中药反药甘草组的试验观察[J].中国兽医杂志,1981,(3):1013.
[6]四川农学院“中药十八反科研组”.中药“十八反”的初步实验研究[J].辽宁畜牧兽医,1977,(5):3639.
[7]王景霞,耿国艳,柳强,等.中药“十八反”药对“藻戟遂芫俱战草”抗癌作用的实验研究[C]//中华中医药学会.2012第五届全国临床中药学学术研讨会论文集,2012:5.
[8]徐芝秀,石苏英,金科涛,等.甘草与海藻、大戟、芫花配伍对大鼠肝脏CYP2E1酶活性及mRNA表达的影响[J].中国药物与临床,2007,7(7):493495.
[9]何益军,石苏英,金科涛,等.甘草与大戟甘遂芫花配伍对大鼠肝脏细胞色素P4501A2酶活性的影响[J].中国药物与临床,2007,7(4):278280.
[10]吕岫华,王颖,陈静,等.大戟甘遂芫花俱战草的实验研究[J].中华中医药杂志,2009,S1:57.
[11]杨致礼,陈怀涛,王尊国,等.在急性肝损伤条件下大戟反甘草的实验研究[J]. 中国兽医杂志,1990,16(8):4041.
[12]袁永久,施心路.中药“十八反”中部分禁忌中药对大型蚤的毒理试验研究[J]. 中国现代医生,2007,45(19):12,8.
[13]黄文权,程相岭,肖鸿,等.中药十八反中部分禁忌中药的毒理实验研究[J].成都中医药大学学报,2001,24(1):4547.
[14]王天益,汪开毓,柳仲华.在生理和病理条件下十八反配伍禁忌的实验研究[J].四川农业大学学报,1994,12(1):113117.
[15]黄文权,罗羽.甘草与甘遂、大戟、海藻、芫花配伍对大鼠心、肝、肾功能的影响(英文)[J].中国临床康复,2004,8(18):36823683.
[16]黄文权,罗羽.甘草大戟同用对大鼠心肝肾功能及病理形态的影响(英文)[J]. 中国临床康复,2004,8(30):68046805.
[17]Wang XM, Peng YR, Jing XY, et al. In vitro and in vivo assessment of CYP2C9mediated herbherb interaction of Euphorbiae Pekinensis Radix and Glycyrrhizae Radix[J]. Frontiers in pharmacology,2014,(5): 18.
[18]金恩波,姜名瑛,黄启福,等.中药十八反的药理研究——芫花、大戟、甘遂、海藻与甘草配伍时的相互作用[J].中成药研究,1982,(2):3033.
[19]肖庆慈,毛小平,郭桂森,等.生甘草与炙京大戟配伍后部分药理实验研究[J]. 云南中医学院学报,1988,11(4):3739.
[20]衡晴晴,卞勇,李璘,等.海藻、大戟、甘遂和芫花分别与不同剂量的甘草配伍对小鼠肠功能的影响[J].中国药理学与毒理学杂志,2013,27(3):374378.
[21]夏成云,高月,周京国,等.大戟配伍甘草对大鼠肝功能及肝脏微粒体中CYP3A2的影响[J].中国中医急症,2006,15(9):10131015,1066.
[22]丁爱华,华永庆,段金廒,等.甘草与大戟、甘遂、芫花的反药组合对大鼠离体回肠运动的影响[J].南京中医药大学学报,2012,28(4):345349.
[23]杨致礼,王佑之,吴成林,等.中药“十八反”在小白鼠上的毒性试验中药“十八反”研究报告之一[J].甘肃农大学报,1982,(1):4652.
[24]李冠军.甘草反大戟的试验研究[J].畜牧与饲料科学,2011,32(2):78.
[25]崔珉,陈方良,张素云.大戟、芫花、甘遂反甘草的初步实验研究[J].中医杂志,1966,(1):3940.
[26]吴秀稳,彭玉帅,王如峰,等.甘草配伍大戟的体外肝毒性研究[J].药物评价研究,2014,37(2),122125.
[27]王钢,宋九华,伏秦超,等.大戟海藻芫花和甘遂与甘草配伍对甘草主要成分的影响观察[J].中国兽医杂志,2013,49(1):4345.
[28]杨致礼,王佑之,吴成林,等. “十八反”中海藻、大戟、甘遂和芫花反甘草组的毒性试验[J].中国中药杂志,1989,14(2):4850,64.
[29]杨华春,曲亚玲,杨致礼.大戟、芫花反甘草在小鼠急性肝损伤条件下的毒性研究[J].甘肃农业大学学报,1990,25(2):126130.

相似文献/References:

[1]郭岩松,许皖,钟赣生,等.乌头瓜蒌反药组合宜忌条件的实验研究回顾与评析[J].环球中医药,2015,8(09):1025.[doi:10.3969/jissn.1674-1749.2015.09.001]
 GUO Yan song,XU Wan,ZHONG Gan sheng,et al.Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility aconitum and trichosanthes[J].,2015,8(09):1025.[doi:10.3969/jissn.1674-1749.2015.09.001]
[2]许皖,张建美,钟赣生,等.乌头贝母反药组合宜忌条件的实验研究回顾与评析[J].环球中医药,2015,8(09):1031.[doi:10.3969/jissn.1674-1749.2015.09.002]
 XU Wan,ZHANG Jian mei,ZHONG Gan sheng,et al.Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility aconitum and fritillary[J].,2015,8(09):1031.[doi:10.3969/jissn.1674-1749.2015.09.002]
[3]许皖,张建美,钟赣生,等.乌头半夏反药组合宜忌条件的实验研究回顾与评析[J].环球中医药,2015,8(09):1038.[doi:10.3969/jissn.1674-1749.2015.09.003]
 XU Wan,ZHANG Jian mei,ZHONG Gan sheng,et al.Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility aconitum and pinellia ternate[J].,2015,8(09):1038.[doi:10.3969/jissn.1674-1749.2015.09.003]
[4]修琳琳,钟赣生,张建美,等.海藻甘草反药组合宜忌条件的实验研究回顾与评析[J].环球中医药,2015,8(09):1044.[doi:10.3969/jissn.1674-1749.2015.09.004]
 XIU Lin lin,ZHONG Gan sheng,ZHANG Jian mei,et al.Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility sargassum and glycyrrhiza[J].,2015,8(09):1044.[doi:10.3969/jissn.1674-1749.2015.09.004]
[5]修琳琳,钟赣生,张建美,等.芫花甘草反药组合宜忌条件的实验研究回顾与评析[J].环球中医药,2015,8(09):1050.[doi:10.3969/jissn.1674-1749.2015.09.005]
 XIU Lin lin,ZHONG Gan sheng,ZHANG Jian mei,et al.Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility genkwa flos and glycyrrhiza[J].,2015,8(09):1050.[doi:10.3969/jissn.1674-1749.2015.09.005]
[6]张建美,许皖,钟赣生,等.甘遂甘草反药组合宜忌条件的实验研究回顾与评析[J].环球中医药,2015,8(09):1053.[doi:10.3969/jissn.1674-1749.2015.09.006]
 ZHANG Jian mei,XU Wan,ZHONG Gan sheng,et al.Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility kansui radix and glycyrrhiza[J].,2015,8(09):1053.[doi:10.3969/jissn.1674-1749.2015.09.006]
[7]郭岩松,许皖,钟赣生,等.人参藜芦反药组合宜忌条件的实验研究回顾与评析[J].环球中医药,2015,8(09):1064.[doi:10.3969/jissn.1674-1749.2015.09.008]
 GUO Yan song,XU Wan,ZHONG Gan sheng,et al.Review on the experimental studies of suitable and contraindicant conditions of Chinese medicine antagonism compatibility ginseng and veratrum nigrum[J].,2015,8(09):1064.[doi:10.3969/jissn.1674-1749.2015.09.008]
[8]郭岩松,柳海艳,钟赣生,等.甘遂半夏汤加减甘遂及不同品种甘草对腹水模型大鼠心肝肾功能的影响[J].环球中医药,2016,9(05):527.[doi:10.3969/j.issn.1674-1749.2016.05.003]
 GUO Yan-song,LIU Hai-yan,ZHONG Gan-sheng,et al.Comparing the effect of Gansui Banxia decoction plus or reduce kansui and varieties of glycyrrhiza on heart, liver and kidney function of ascites model rat[J].,2016,9(09):527.[doi:10.3969/j.issn.1674-1749.2016.05.003]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 1900-01-01